Ashkan Shoamanesh: OCEANIC-STROKE Focus on Stroke Subtypes and Response to Asundexian at ISC26
Ashkan Shoamanesh, Associate Professor of Medicine (Neurology), Marta and Owen Boris Chair in Stroke Research and Care at McMaster University, shared on LinkedIn:
”It was a pleasure to discuss the results of our secondary analyses of the OCEANIC-STROKE trial focused on qualifying ischemic stroke subtype and response to asundexian with Video Journal of Neurology (VJNeurology) at ISC26.
Our results demonstrate consistency in the treatment effect of asundexian irrespective of underlying etiology, including robust reductions in ischemic stroke in patients with qualifying stroke due to small vessel occlusive disease (HR 0.61, 95%CI 0.46-0.81) and embolic stroke of undetermined source (HR 0.53, 95%CI 0.37-0.78), without excess in major bleeding or intracranial hemorrhage!
Eagerly awaiting approval of asundexian for the betterment of stroke prevention in our patients with non-cardioembolic ischemic stroke or high-risk TIA.”
Stay updated with Hemostasis Today.
-
Feb 22, 2026, 06:43Aurelio Maggio: Is It Time to Align Thalassemia Biology with Regulatory Science?
-
Feb 22, 2026, 06:32Priyansh Shah: Integrating Food-Based Nutrition Interventions Into Health Care Delivery
-
Feb 22, 2026, 06:18Thomas Reiser: How Can Medical and Healthcare Associations Stay Impactful in a Changing Environment?
-
Feb 22, 2026, 05:58Mark Crowther: Why Leaders Must Model What They Expect
-
Feb 21, 2026, 15:58Addressing Underdiagnosis and Care Inequities in Women and Girls with Bleeding Disorders – WFH
-
Feb 21, 2026, 15:49Sheharyar Raza: The Leaky Pipeline of AI and Machine Learning in Transfusion Medicine
-
Feb 21, 2026, 15:21Joanna Sadowska: Watching a Stem Cell Divide Reveals Life’s Blueprint
-
Feb 21, 2026, 14:43Gashaw Arega: Demonstrating Impact Through Blood Donation for Childhood Cancer
-
Feb 21, 2026, 14:42Travel Tips for Attending WFH 2026 World Congress in Kuala Lumpur